My research focuses on how social influences shape individuals’ health behaviors in both constructive (e.g., physical activity) and risky ways (e.g., alcohol use). I take a translational approach to my research in that I aim to understand how social processes, such as normative influences, relate to behavior so that we can leverage these influences to reduce harm and improve health.
Specific areas of interest include alcohol and other substance use, mental health, and gambling/sports betting. My primary focus is helping young adults during the transition into adulthood.
I have a background in sport psychology, and am passionate about helping athletes navigate the unique stressors involved in high-level sport. In this domain, I serve as a fellow at the U.S. Center for Mental Health and Sport.
My scholarship is dedicated to reducing behavioral health disparities in Indigenous, immigrant and refugee communities. I have 13 years of experience and expertise in community-based participatory research (CBPR) science and practice, mixed-methods multi-level research design, cultural adaptation and translation of evidenced based interventions and culture-based practices, survey and measurement development, and dissemination and translation of findings. I am interested in examining culture-centered, land-based healing practices and mechanisms in addressing substance use, sexual health, and climate change impact.
The Pravetoni group focuses on development and translation of medical interventions against substance use disorders (SUD) and other chemical and biological threats. Current efforts are: 1) vaccines, monoclonal antibodies (mAb), and small molecules to treat or prevent SUD, opioid use disorders (OUD) and overdose, 2) mechanisms and biomarkers underlying or predicting efficacy of immunotherapeutics and medications in pre-clinical models of SUD and OUD patients, 3) novel strategies to enhance vaccine or medication efficacy, including immunomodulators, small molecules, adjuvants, nanoparticles, polymers and other delivery platforms, 4) Vaccines, mAb, and clinical biomarkers against infectious diseases (e.g., Pseudomonas aeruginosa and novel coronavirus SARS-CoV-2), 5) biosensors for field detection or diagnosis.
My clinical and research work focus on ways to improve care for children with complex neurodevelopmental and behavioral concerns, especially in the context of prenatal substance exposures and fetal alcohol spectrum disorders (FASD).
Current projects include developing training to reduce stigma and improve accurate retrospective screening for prenatal alcohol exposure; examining factors influencing response to the Families Moving Forward Program for FASD; and, evaluating the clinical utility of the proposed diagnosis ND-PAE.
Dr. Walukevich-Dienst (hear my name) is a licensed clinical psychologist and an Assistant Professor at the University of Washington.
Her research is focused on identifying psychosocial and contextual factors associated with alcohol and cannabis misuse and co-use among young adults, including social influences (e.g., romantic partners, use partnerships), affect management motives, co-occurring mental health concerns, and high-risk substance use events and contexts.
Dr. Walukevich-Dienst aims to leverage this information to develop and test innovative, technology-informed prevention and intervention efforts to disseminate in real world settings.
She also provides psychotherapy to patients at the University of Washington’s Outpatient Psychiatry Clinic and provides supervision and training to psychology graduate students and psychiatry residents in Cognitive Behavioral Therapy.
Link to Dr. Walukevich-Dienst’s CV.
Dr. Prater holds a doctorate in public health from the Ohio State University, with a focus in health services research, pragmatic intervention development and policy evaluation. Her work focuses on understanding the circumstances around firearm suicide among vulnerable populations and developing health systems interventions for suicide prevention through firearm safety. Using a public health lens, she works on tailoring interventions to meet the unique needs of vulnerable populations (e.g. dementia, terminal illness) at increased risk for suicidal thoughts and behaviors. She is currently funded by the National Institutes on Aging and the American Foundation for Suicide Prevention to produce clinical decision-making tools to help persons with early dementia, their care partners, and primary clinicians, to make safer plans for firearm storage.
Koriann Cox, Ph.D. graduated from Northeastern University and is licensed in the state of Washington. She completed a postdoctoral fellowship in co-occurring addiction and mental health and has a range of clinical experience with a variety of concerns including depression, anxiety, trauma, reproductive mental health, and substance and behavioral addictions. Dr. Cox’s strengths-focused approach emphasizes the mutual development of goals for therapy and ongoing collaboration between herself, the patient, and the care team. Dr. Cox uses a number of therapeutic modalities including but not limited to Cognitive Behavioral Therapy, Acceptance and Commitment Therapy, and Cognitive Processing Therapy.
I am a counseling psychologist interested in developing and implementing culturally responsive, evidence-informed, family-centered, and non-pathologizing interventions. My practice and research are informed by postmodern ideas, especially narrative therapy. I provide clinical services at the Madison Clinic at Harborview Medical Center.
